76.8 F
San Diego
Wednesday, Jul 17, 2024
-Advertisement-

Neil Reisman Joins Board at Mirati Therapeutics

San Diego-based biotechnology company Mirati Therapeutics Inc., a clinical-stage company developing targeted oncology products, has added Neil Reisman to its board of directors.

Reisman, a lawyer and certified public accountant with more than 30 years of business experience with an emphasis on finance, operations, legal, tax and transactional experience, is a managing director and board member at billionaire Joe Lewis’ investment company, Tavistock Group.

He was chief operating officer, chief financial officer and general counsel at another San Diego biotechnology company, CovX, when he joined Tavistock in 2004. Since then, he has held operational roles at companies within Tavistock Group, including serving a stint as chairman of its investment committee.

Reisman earned a law degree in 1986 from the University of Pennsylvania and a bachelor’s degree in accountancy in 1983 from the University of Illinois.

Earlier this year, Mirati (NASDAQ: MRTX) raised $68.7 million in a public offering. The company said the funds were for clinical development of three product candidates, development of preclinical programs and working capital.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-